Version July 2025
Treatment of uncomplicated malaria due to susceptible strains of Plasmodium falciparum.
Children, Adolescents, and Adults:
5 to <8 kg: Oral: Piperaquine 160 mg/artenimol 20 mg once daily for 3 days.
8 to <11 kg: Oral: Piperaquine 240 mg/artenimol 30 mg once daily for 3 days.
11 to <17 kg: Oral: Piperaquine 320 mg/artenimol 40 mg once daily for 3 days.
17 to <25 kg: Oral: Piperaquine 480 mg/artenimol 60 mg once daily for 3 days.
25 to <36 kg: Oral: Piperaquine 640 mg/artenimol 80 mg once daily for 3 days.
36 to <60 kg: Oral: Piperaquine 960 mg/artenimol 120 mg once daily for 3 days.
60 to <80 kg: Oral: Piperaquine 1,280 mg/artenimol 160 mg once daily for 3 days.
>80 kg: Oral: Piperaquine 1,600 mg/artenimol 200 mg once daily for 3 days.
Product available in various countries; not currently available in the United States.
Tablet, Oral: Piperaquine tetraphosphate 160 mg and artenimol 20 mg, piperaquine tetraphosphate 320 mg and artenimol 40 mg
